Development of wound healing biomaterials based on bacterial exopolysaccharides

Detalhes bibliográficos
Autor(a) principal: Ramos, Kleyde Delsy Delgado
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/129170
Resumo: Currently, biopolymers have aroused great interest mainly in the food, pharmaceutical, cosmetic, and also in the biomedical fields, due to the intelligent and versatile properties that present, namely, biocompatibility, biodegradability, and non-toxicity. In addition to these properties, many polymers have vital characteristics that assist in wound healing processes and, when incorporated into nanoparticles of elements such as silver (Ag), gold (Au), and selenium (Se), further increase the effectiveness of these polymers. Therefore, the main objective of this study was to determine the best conditions for the preparation of biocomposites for application in the treatment of wounds, using different extracellular bacterial polysaccharides (EPSs) (EPS1, EPS2, EPS3, EPS4, and FucoPol) as reducing and stabilizing agents for the synthesis of silver nanoparticles (AgNP), gold (AuNP) and selenium (SeNP). EPSs were characterized as to the composition in sugars and substituting groups, because, depending on the composition, they can interfere in some way in the properties of each one. EPS1 is composed mainly of mannose (56.1% mol), EPS2 and EPS3 are composed mainly of glucose, 67% mol and 39.1% mol, respectively, EPS4 is composed mainly of glucuronic acid (55.9% mol) and FucoPol by fucose (34.9 mol%). Biocomposites were also characterized by UV-vis spectroscopy, FTIR, TGA, XRD, DLS, Zeta potential and ICP. Cytotoxicity and wound healing effect of EPSs and EPS/NPs biocomposites were analyzed in human keratinocyte cells (HaCaT cell line). The samples were tested using a polymer concentration of 62.5 - 1000 mg/L and none of the samples showed cytotoxicity, except for the EPS3/Ag+ biocomposite when tested at a polymer concentration above 125 mg/L, with a content Ag+ above 6.9 mg/L (decreased cell viability by ~91.9%). On the other hand, among all EPSs and their functionalized materials, FucoPol and the biocomposite FucoPol/AgNP exhibited a greater capacity to promote keratinocyte migration in vitro. Although EPS1 did not present wound healing effect, the biocomposites EPS1/AgNP (100 mg/L) and EPS1/AuNP (500 mg/L) showed to promote the migration of HaCaT cells. The results obtained suggest that both FucoPol and the biocomposite FucoPol/AgNP, as well as the biocomposites EPS1/AgNP and EPS1/AuNP, may have potential application in dermo-cosmetics, mainly in wound healing mechanisms.
id RCAP_294c1df0435fc02bc26f8d02caf6811f
oai_identifier_str oai:run.unl.pt:10362/129170
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Development of wound healing biomaterials based on bacterial exopolysaccharidesExopolysaccharidesnanoparticlescytotoxicitywound healingbiopolymerbiocomposites synthesisDomínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e TecnologiasCurrently, biopolymers have aroused great interest mainly in the food, pharmaceutical, cosmetic, and also in the biomedical fields, due to the intelligent and versatile properties that present, namely, biocompatibility, biodegradability, and non-toxicity. In addition to these properties, many polymers have vital characteristics that assist in wound healing processes and, when incorporated into nanoparticles of elements such as silver (Ag), gold (Au), and selenium (Se), further increase the effectiveness of these polymers. Therefore, the main objective of this study was to determine the best conditions for the preparation of biocomposites for application in the treatment of wounds, using different extracellular bacterial polysaccharides (EPSs) (EPS1, EPS2, EPS3, EPS4, and FucoPol) as reducing and stabilizing agents for the synthesis of silver nanoparticles (AgNP), gold (AuNP) and selenium (SeNP). EPSs were characterized as to the composition in sugars and substituting groups, because, depending on the composition, they can interfere in some way in the properties of each one. EPS1 is composed mainly of mannose (56.1% mol), EPS2 and EPS3 are composed mainly of glucose, 67% mol and 39.1% mol, respectively, EPS4 is composed mainly of glucuronic acid (55.9% mol) and FucoPol by fucose (34.9 mol%). Biocomposites were also characterized by UV-vis spectroscopy, FTIR, TGA, XRD, DLS, Zeta potential and ICP. Cytotoxicity and wound healing effect of EPSs and EPS/NPs biocomposites were analyzed in human keratinocyte cells (HaCaT cell line). The samples were tested using a polymer concentration of 62.5 - 1000 mg/L and none of the samples showed cytotoxicity, except for the EPS3/Ag+ biocomposite when tested at a polymer concentration above 125 mg/L, with a content Ag+ above 6.9 mg/L (decreased cell viability by ~91.9%). On the other hand, among all EPSs and their functionalized materials, FucoPol and the biocomposite FucoPol/AgNP exhibited a greater capacity to promote keratinocyte migration in vitro. Although EPS1 did not present wound healing effect, the biocomposites EPS1/AgNP (100 mg/L) and EPS1/AuNP (500 mg/L) showed to promote the migration of HaCaT cells. The results obtained suggest that both FucoPol and the biocomposite FucoPol/AgNP, as well as the biocomposites EPS1/AgNP and EPS1/AuNP, may have potential application in dermo-cosmetics, mainly in wound healing mechanisms.Atualmente, os biopolímeros têm despertado grande interesse principalmente na área alimentar, farmacêutica, cosmética e também na área biomédica, devido às propriedades inteligentes e versáteis que apresentam, nomeadamente, biocompatibilidade, biodegradabilidade e não toxicidade. Além dessas propriedades, muitos polímeros possuem características vitais que ajudam em processos de cicatrização de feridas e quando incorporados com nanopartículas de elementos como a prata (Ag), ouro (Au) e selénio (Se), aumentam ainda mais a eficácia desses polímeros. Assim sendo, o principal objetivo deste estudo foi determinar as melhores condições de preparação de biocompósitos para aplicação em tratamento de feridas, utilizando diferentes polissacáridos bacterianos extracelulares (EPSs) (EPS1, EPS2, EPS3, EPS4 e FucoPol) como agentes redutores e estabilizadores para a síntese de nanopartículas de prata (AgNP), ouro (AuNP) e selénio (SeNP). Os EPSs foram caracterizados quanto à composição em açúcares e grupos substituintes, pois, dependendo da composição, podem interferir de certa forma nas propriedades apresentadas por cada um. O EPS1 é composto principalmente por manose (56.1 %mol), o EPS2 e o EPS3 são compostos principalmente por glucose, 67 %mol e 39.1 %mol respectivamente, o EPS4 é composto maioritariamente por ácido glucurónico (55.9 %mol) e o FucoPol por fucose (34.9 %mol). Os biocompósitos também foram caracterizados por espectroscopia UV-vis, FTIR, TGA, XRD, DLS, potencial Zeta e por ICP. A citotoxicidade e o efeito de cicatrização de feridas dos EPS e dos biocompósitos EPSs/NPs foram analisados em células de queratinócitos humanos (linha celular HaCaT). As amostras foram testadas usando uma concentração de polímero de 62.5-1000 mg/L e nenhuma amostra apresentou citotoxicidade, excepto para o biocompósito EPS3/Ag+ quando testado em uma concentração de polímero acima de 125 mg/L, com um teor de Ag+ acima de 6.9 mg/L (diminuição da viabilidade cellular em ~ 91.9%). Por outro lado, entre todos os EPSs e seus materiais funcionalizados, o FucoPol e o biocompósito FucoPol/AgNP exibiram uma maior capacidade de promover a migração in vitro dos queratinócitos. Embora o EPS1 não tenha apresentado efeito cicatrizante, os biocompósitos EPS1/AgNP (100 mg/L) e EPS1/AuNP (500 mg/L) mostraram promover a migração de células HaCaT. Os resultados obtidos sugerem que tanto o FucoPol e o biocompósito FucoPol/AgNP, bem como os biocompósitos EPS1/AgNP e EPS1/AuNP podem ter potencial aplicação na dermocosmética, sobretudo nos mecanismos de cicatrização de feridas.Freitas, Maria FilomenaSerra, AnaRUNRamos, Kleyde Delsy Delgado2021-12-14T12:56:25Z2021-102021-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/129170enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:08:25Zoai:run.unl.pt:10362/129170Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:46:29.093257Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Development of wound healing biomaterials based on bacterial exopolysaccharides
title Development of wound healing biomaterials based on bacterial exopolysaccharides
spellingShingle Development of wound healing biomaterials based on bacterial exopolysaccharides
Ramos, Kleyde Delsy Delgado
Exopolysaccharides
nanoparticles
cytotoxicity
wound healing
biopolymer
biocomposites synthesis
Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias
title_short Development of wound healing biomaterials based on bacterial exopolysaccharides
title_full Development of wound healing biomaterials based on bacterial exopolysaccharides
title_fullStr Development of wound healing biomaterials based on bacterial exopolysaccharides
title_full_unstemmed Development of wound healing biomaterials based on bacterial exopolysaccharides
title_sort Development of wound healing biomaterials based on bacterial exopolysaccharides
author Ramos, Kleyde Delsy Delgado
author_facet Ramos, Kleyde Delsy Delgado
author_role author
dc.contributor.none.fl_str_mv Freitas, Maria Filomena
Serra, Ana
RUN
dc.contributor.author.fl_str_mv Ramos, Kleyde Delsy Delgado
dc.subject.por.fl_str_mv Exopolysaccharides
nanoparticles
cytotoxicity
wound healing
biopolymer
biocomposites synthesis
Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias
topic Exopolysaccharides
nanoparticles
cytotoxicity
wound healing
biopolymer
biocomposites synthesis
Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias
description Currently, biopolymers have aroused great interest mainly in the food, pharmaceutical, cosmetic, and also in the biomedical fields, due to the intelligent and versatile properties that present, namely, biocompatibility, biodegradability, and non-toxicity. In addition to these properties, many polymers have vital characteristics that assist in wound healing processes and, when incorporated into nanoparticles of elements such as silver (Ag), gold (Au), and selenium (Se), further increase the effectiveness of these polymers. Therefore, the main objective of this study was to determine the best conditions for the preparation of biocomposites for application in the treatment of wounds, using different extracellular bacterial polysaccharides (EPSs) (EPS1, EPS2, EPS3, EPS4, and FucoPol) as reducing and stabilizing agents for the synthesis of silver nanoparticles (AgNP), gold (AuNP) and selenium (SeNP). EPSs were characterized as to the composition in sugars and substituting groups, because, depending on the composition, they can interfere in some way in the properties of each one. EPS1 is composed mainly of mannose (56.1% mol), EPS2 and EPS3 are composed mainly of glucose, 67% mol and 39.1% mol, respectively, EPS4 is composed mainly of glucuronic acid (55.9% mol) and FucoPol by fucose (34.9 mol%). Biocomposites were also characterized by UV-vis spectroscopy, FTIR, TGA, XRD, DLS, Zeta potential and ICP. Cytotoxicity and wound healing effect of EPSs and EPS/NPs biocomposites were analyzed in human keratinocyte cells (HaCaT cell line). The samples were tested using a polymer concentration of 62.5 - 1000 mg/L and none of the samples showed cytotoxicity, except for the EPS3/Ag+ biocomposite when tested at a polymer concentration above 125 mg/L, with a content Ag+ above 6.9 mg/L (decreased cell viability by ~91.9%). On the other hand, among all EPSs and their functionalized materials, FucoPol and the biocomposite FucoPol/AgNP exhibited a greater capacity to promote keratinocyte migration in vitro. Although EPS1 did not present wound healing effect, the biocomposites EPS1/AgNP (100 mg/L) and EPS1/AuNP (500 mg/L) showed to promote the migration of HaCaT cells. The results obtained suggest that both FucoPol and the biocomposite FucoPol/AgNP, as well as the biocomposites EPS1/AgNP and EPS1/AuNP, may have potential application in dermo-cosmetics, mainly in wound healing mechanisms.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-14T12:56:25Z
2021-10
2021-10-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/129170
url http://hdl.handle.net/10362/129170
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138068418002944